Skip to main content
. Author manuscript; available in PMC: 2013 Feb 28.
Published in final edited form as: N Engl J Med. 2003 Jul 17;349(3):247–257. doi: 10.1056/NEJMoa022289

Table 3.

Univariate Analysis of Survival among Patients with Stage II or Stage III Colon Cancer According to Microsatellite-Instability Status or Adjuvant-Chemotherapy Status.*

Analysis No. of Patients Patients Surviving at 5 Yr P Value Patients Surviving without Disease at 5 Yr P Value
% (95% CI) % (95% CI)
According to microsatellite-instability status

All patients 570
 Stability or low-frequency instability 475 71.9 (67.9–76.1) 0.07 64.1 (59.9–68.6) 0.04
 High-frequency instability 95 78.4 (70.3–87.3) 75.3 (67.0–84.6)

Patients receiving no adjuvant chemotherapy 287
 Stability or low-frequency instability 245 68.4 (62.7–74.6) 0.004 58.7 (52.8–65.3) 0.004
 High-frequency instability 42 88.0 (78.7–98.4) 82.9 (72.1–95.3)

Patients receiving adjuvant chemotherapy 283
 Stability or low-frequency instability 230 75.5 (70.1–81.4) 0.66 69.8 (64.1–76.0) 0.85
 High-frequency instability 53 70.7 (59.2–84.5) 69.3 (57.8–83.1)

According to adjuvant-chemotherapy status
All patients 570
 Adjuvant chemotherapy 283 74.6 (69.6–80.0) 0.12 69.7 (64.5–75.3) 0.06
 No adjuvant chemotherapy 287 71.2 (66.1–76.8) 62.3 (56.9–68.2)

Stability or low-frequency instability 475
 Adjuvant chemotherapy 230 75.5 (70.1–81.4) 0.02 69.8 (64.1–76.0) 0.01
 No adjuvant chemotherapy 245 68.4 (62.7–74.6) 58.7 (52.8–65.3)

High-frequency instability 95
 Adjuvant chemotherapy 53 70.7 (59.2–84.5) 0.07 69.3 (57.8–83.1) 0.11
 No adjuvant chemotherapy 42 88.0 (78.7–98.4) 82.9 (72.1–95.3)
*

P values are for the comparison between the rate in the given subgroup and that in the subgroup below it. CI denotes confidence interval.